Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - Formulators
  4. /Rubicon Research Ltd
MomentumDeep Value

Rubicon Research Ltd: Why Is It Outperforming Nifty 500?

Active
RS +23.2%Average12w StreakAccelerating

In Week of May 10, 2026, Rubicon Research Ltd (Pharma - Formulators) is outperforming Nifty 500 with +23.2% relative strength. Fundamentals: Average. On a 12-week streak.

Rubicon Research Ltd Key Facts

PE Ratio
93.5x
Price/Book
11.26x
Market Cap
₹15,747 Cr
PAT Growth YoY
+92%
Revenue Growth YoY
+52%
OPM
23.0%
RS vs Nifty 500
+23.2%

What's Happening

📊Debt increased 36% YoY — leverage rising
💰Trading 35% above estimated fair value — significant premium

Key Numbers

PAT Growth YoY
+92%
Insufficient Data
Revenue YoY
+52%
Insufficient Data
Operating Margin
23.0%
+100 bps YoY
PE Ratio
93.5
PEG Ratio
2.83
EV/EBITDA
52.5
Current Price
₹956
Fundamental Score
54/100
Average
3Y PAT CAGR
+61%
Market Cap
15.7K Cr
Valuation
Significantly Overvalued

12-Week Performance

Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.

12 weeks agoThis week

How Fast Is Rubicon Research Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+52%+60%Insufficient Data
PAT (Net Profit)+92%+61%Insufficient Data
OPM23.0%+100 bpsExpanding

Other Top Pharma - Formulators Stocks Beating Nifty 500

Sun Pharmaceutical Industries Ltd
Strong
+10.4%
Torrent Pharmaceuticals Ltd
Average • 12w streak
+12.6%
Lupin Ltd
Strong • 12w streak
+10.8%
Dr Reddys Laboratories Ltd
Average • 11w streak
+5.6%
Mankind Pharma Ltd
Average
+19.4%
← Back to Pharma - FormulatorsDashboard

Frequently Asked Questions: Rubicon Research Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Rubicon Research Ltd's latest quarterly results?

Rubicon Research Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: +92.1% (insufficient_data)
  • Revenue Growth YoY: +52.1%
  • Operating Margin: 23.0% (expanding)

Is Rubicon Research Ltd's profit growing or declining?

Rubicon Research Ltd's profit is growing with an insufficient_data trend.

  • PAT Growth YoY: +92.1% (latest quarter)
  • PAT Growth QoQ: +35.2% (sequential)
  • 3-Year PAT CAGR: +60.9%
  • Trend: Insufficient_data — consistent growth pattern

What is Rubicon Research Ltd's revenue growth trend?

Rubicon Research Ltd's revenue growth trend is insufficient_data.

  • Revenue Growth YoY: +52.1%
  • Revenue Growth QoQ: +15.5% (sequential)
  • 3-Year Revenue CAGR: +59.9%

How is Rubicon Research Ltd's operating margin trending?

Rubicon Research Ltd's operating margin is expanding.

  • Current OPM: 23.0%
  • OPM Change YoY: +1.0% basis points
  • OPM Change QoQ: 0.0% basis points

What is Rubicon Research Ltd's 3-year profit and revenue CAGR?

Rubicon Research Ltd's long-term compounding rates

  • 3-Year Profit CAGR: +60.9%
  • 3-Year Revenue CAGR: +59.9%

Is Rubicon Research Ltd's growth accelerating or decelerating?

Rubicon Research Ltd's earnings growth is insufficient_data with strong momentum on a sequential basis.

  • YoY Acceleration: +33.3% bps
  • Sequential Acceleration: +9.6% bps

Is Rubicon Research Ltd overvalued or undervalued?

Rubicon Research Ltd appears significantly overvalued based on our fair value analysis.

  • Valuation Signal: Significantly Overvalued
  • Current PE: 93.5x
  • Price-to-Book: 24.3x

What is Rubicon Research Ltd's current PE ratio?

Rubicon Research Ltd's current PE ratio is 93.5x.

  • Current PE: 93.5x
  • Market Cap: 15.7K Cr

How does Rubicon Research Ltd's valuation compare to its history?

Rubicon Research Ltd's current PE is 93.5x.

  • Current PE: 93.5x
  • Valuation Assessment: Significantly Overvalued

What is Rubicon Research Ltd's price-to-book ratio?

Rubicon Research Ltd's price-to-book ratio is 24.3x.

  • Price-to-Book (P/B): 24.3x
  • Book Value per Share: ₹39
  • Current Price: ₹956

Is Rubicon Research Ltd a fundamentally strong company?

Rubicon Research Ltd is rated Average with a fundamental score of 54/100. This score is calculated from objective financial metrics

  • Revenue Growth YoY: +52.1% (10% weight)
  • PAT Growth YoY: +92.1% (10% weight)
  • PAT Growth QoQ: +35.2% (10% weight)
  • Margins expanding (10% weight)
  • PEG Ratio: 2.8x vs sector median (15% weight)
  • EV/EBITDA: 52.5x vs sector median (15% weight)

Is Rubicon Research Ltd debt free?

Rubicon Research Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹418 Cr

What is Rubicon Research Ltd's return on equity (ROE) and ROCE?

Rubicon Research Ltd's return ratios over recent years

  • FY2023: ROCE 1.0%
  • FY2024: ROCE 19.0%
  • FY2025: ROCE 26.0%

Is Rubicon Research Ltd's cash flow positive?

Rubicon Research Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹159 Cr
  • Free Cash Flow (FCF): ₹94 Cr
  • CFO/PAT Ratio: 119% (strong cash conversion)

What is Rubicon Research Ltd's dividend yield?

Rubicon Research Ltd currently does not pay a significant dividend (yield 0.00%).

  • Dividend Yield: 0.00%
  • Current Price: ₹956

Who holds Rubicon Research Ltd shares — promoters, FII, DII?

Rubicon Research Ltd's shareholding pattern (Mar 2026)

  • Promoters: 59.9%
  • FII (Foreign): 7.5%
  • DII (Domestic): 10.0%
  • Public: 22.6%

Is promoter holding increasing or decreasing in Rubicon Research Ltd?

Rubicon Research Ltd's promoter holding has decreased recently.

  • Current Promoter Holding: 59.9% (Mar 2026)
  • Previous Quarter: 60.0% (Dec 2025)
  • Change: -0.13% (decreasing — worth monitoring)

How long has Rubicon Research Ltd been outperforming Nifty 500?

Rubicon Research Ltd has been outperforming Nifty 500 for 12 consecutive weeks, indicating strong sustained outperformance.

Is Rubicon Research Ltd a new momentum entry or an established outperformer?

Rubicon Research Ltd is an established outperformer with 12 weeks of consecutive Nifty 500 outperformance.

Is Rubicon Research Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Rubicon Research Ltd may be worth studying

  • Earnings growing at +92.1% YoY
  • Operating margins are expanding — OPM at 23.0%
  • Cash flow is positive — CFO ₹159 Cr

What is the investment thesis for Rubicon Research Ltd?

Rubicon Research Ltd investment thesis summary:

Research Signals (Bull Case)

  • Revenue growing at +52.1% YoY
  • Margins expanding

Risk Factors (Bear Case)

  • Appears significantly overvalued

What is the future outlook for Rubicon Research Ltd?

Rubicon Research Ltd's forward outlook based on current data signals

  • Earnings Trend: insufficient_data
  • Revenue Trend: insufficient_data
  • Margin Trend: expanding
  • Valuation: Significantly Overvalued

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.